Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Byrd

Showing results (51-60 of 681) with videos related to

Pageof 69
Sort By:
The New England Journal of Medicine|September 27, 2013
Ibrutinib in relapsed chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Danelle F James
Hematology. American Society of Hematology. Education Program|November 25, 2004
Chronic lymphocytic leukemiaJohn C Byrd, Stephan Stilgenbauer, Ian W Flinn
Frontiers in Physiology|April 9, 2015
Tetraspanins as therapeutic targets in hematological malignancy: a concise reviewKyle A Beckwith, John C Byrd, Natarajan Muthusamy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Translating PI3K-Delta Inhibitors to the Clinic in Chronic Lymphocytic Leukemia: The Story of CAL-101 (GS1101)John C Byrd, Jennifer A Woyach, Amy J Johnson
Seminars in Oncology|April 5, 2016
Chronic lymphocytic leukemia: recent progress and current challengesJennifer A Woyach, Amy J Johnson, John C Byrd
Seminars in Oncology|August 27, 2003
Rituximab in B-cell chronic lymphocytic leukemiaThomas S Lin, Margaret S Lucas, John C Byrd
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?Charles F Eisenbeis, Michael A Caligiuri, John C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Changing the way we think about chronic lymphocytic leukemiaThomas S Lin, Michael R Grever, John C Byrd
Blood|June 21, 2012
The B-cell receptor signaling pathway as a therapeutic target in CLLJennifer A Woyach, Amy J Johnson, John C Byrd
Seminars in Oncology|April 18, 2006
Treatment of relapsed chronic lymphocytic leukemia: old and new therapiesJohn C Byrd, Thomas S Lin, Michael R Grever
Pageof 69

Showing results (51-60 of 681) with videos related to

Sort By:
Pageof 69
The New England Journal of Medicine|September 27, 2013
Ibrutinib in relapsed chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Danelle F James
Hematology. American Society of Hematology. Education Program|November 25, 2004
Chronic lymphocytic leukemiaJohn C Byrd, Stephan Stilgenbauer, Ian W Flinn
Frontiers in Physiology|April 9, 2015
Tetraspanins as therapeutic targets in hematological malignancy: a concise reviewKyle A Beckwith, John C Byrd, Natarajan Muthusamy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Translating PI3K-Delta Inhibitors to the Clinic in Chronic Lymphocytic Leukemia: The Story of CAL-101 (GS1101)John C Byrd, Jennifer A Woyach, Amy J Johnson
Seminars in Oncology|April 5, 2016
Chronic lymphocytic leukemia: recent progress and current challengesJennifer A Woyach, Amy J Johnson, John C Byrd
Seminars in Oncology|August 27, 2003
Rituximab in B-cell chronic lymphocytic leukemiaThomas S Lin, Margaret S Lucas, John C Byrd
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?Charles F Eisenbeis, Michael A Caligiuri, John C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Changing the way we think about chronic lymphocytic leukemiaThomas S Lin, Michael R Grever, John C Byrd
Blood|June 21, 2012
The B-cell receptor signaling pathway as a therapeutic target in CLLJennifer A Woyach, Amy J Johnson, John C Byrd
Seminars in Oncology|April 18, 2006
Treatment of relapsed chronic lymphocytic leukemia: old and new therapiesJohn C Byrd, Thomas S Lin, Michael R Grever
Pageof 69